VivoSim Labs, Inc. last reported quarterly results on Aug 6, 2026, for Q1 FY2027 (the quarter ended Jun 30, 2026): revenue of $18,000 and diluted EPS of -$0.25. It usually reports 2–52 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 6, 2026.
Results for Q2 FY2027, the quarter ending around Sep 30, 2026. Expected on a Friday. Based on how many days after a quarter ends the company has reported recently. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 2–52 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 6, 2026
37 days after quarter end
|
Q1 FY2027
ended Jun 30, 2026
|
0
|
-1
|
-0.25
|
|
Apr 2, 2025
2 days after quarter end
|
Q4 FY2025
ended Mar 31, 2025
|
0
|
7
|
4.21
|
|
May 22, 2019
52 days after quarter end
|
—
ended Mar 31, 2019
|
—
|
—
|
—
|
|
Feb 7, 2019
38 days after quarter end
|
—
ended Dec 31, 2018
|
—
|
—
|
—
|
|
Nov 8, 2018
39 days after quarter end
|
—
ended Sep 30, 2018
|
—
|
—
|
—
|
|
Aug 9, 2018
40 days after quarter end
|
—
ended Jun 30, 2018
|
—
|
—
|
—
|
|
May 31, 2018
61 days after quarter end
|
—
ended Mar 31, 2018
|
—
|
—
|
—
|
|
Feb 8, 2018
39 days after quarter end
|
—
ended Dec 31, 2017
|
—
|
—
|
—
|
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- VIVS (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1497253
- Former names
- ORGANOVO HOLDINGS, INC. (until Apr 23, 2025); REAL ESTATE RESTORATION & RENTAL, INC. (until Oct 31, 2011)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.